Instituto de Medicina Tropical, Faculdade de Medicina, Universidade de São Paulo (IMTSP/USP), São Paulo, Brazil.
Departamento de Salud Publica, Facultad de Ciencias de La Salud, Universidad Nacional Toribio Rodriguez de Mendoza de Amazonas, Chachapoyas, Peru.
Front Cell Infect Microbiol. 2022 Feb 10;12:826039. doi: 10.3389/fcimb.2022.826039. eCollection 2022.
Visceral leishmaniasis caused by in Latin America progress with hepatosplenomegaly, pancytopenia, hypergammaglobulinemia, and weight loss and maybe lethal mainly in untreated cases. miRNAs are important regulators of immune and inflammatory gene expression, but their mechanisms of action and their relationship to pathogenesis in leishmaniasis are not well understood. In the present study, we sought to quantify changes in miRNAs associated with immune and inflammatory pathways using the promastigote infected- human monocytic THP-1 cell model and plasma from patients with visceral leishmaniasis. We identified differentially expressed miRNAs in infected THP-1 cells compared with non-infected cells using qPCR arrays. These miRNAs were submitted to analysis, revealing targets within functional pathways associated with TGF-β, chemokines, glucose metabolism, inflammation, apoptosis, and cell signaling. In parallel, we identified differentially expressed miRNAs in active visceral leishmaniasis patient plasma compared with endemic healthy controls. analysis of these data indicated different predicted targets within the TGF-β, TLR4, IGF-I, chemokine, and HIF1α pathways. Only a small number of miRNAs were commonly identified in these two datasets, notably with miR-548d-3p being up-regulated in both conditions. To evaluate the potential biological role of miR-548d-3p, we transiently transfected a miR-548d-3p inhibitor into infected-THP-1 cells, finding that inhibition of miR-548d-3p enhanced parasite growth, likely mediated through reduced levels of MCP-1/CCL2 and nitric oxide production. Further work will be required to determine how miR-548d-3p plays a role and whether it serves as a potential biomarker of progressive leishmaniasis.
内脏利什曼病由 在拉丁美洲引起,伴有肝脾肿大、全血细胞减少、高γ球蛋白血症和体重减轻,在未经治疗的病例中可能致命。miRNAs 是免疫和炎症基因表达的重要调节剂,但它们的作用机制及其与利什曼病发病机制的关系尚不清楚。在本研究中,我们试图使用 诱导的人单核细胞 THP-1 细胞模型和内脏利什曼病患者的血浆来定量与免疫和炎症途径相关的 miRNAs 的变化。我们使用 qPCR 阵列比较了感染的 THP-1 细胞与未感染细胞之间差异表达的 miRNAs。这些 miRNAs 被提交给 分析,揭示了与 TGF-β、趋化因子、葡萄糖代谢、炎症、细胞凋亡和细胞信号传导相关的功能途径中的靶标。同时,我们比较了活跃的内脏利什曼病患者血浆与地方病健康对照之间差异表达的 miRNAs。对这些数据的 分析表明,在 TGF-β、TLR4、IGF-I、趋化因子和 HIF1α途径中存在不同的预测靶标。在这两个数据集中共鉴定出少数 miRNAs,特别是 miR-548d-3p 在两种情况下均上调。为了评估 miR-548d-3p 的潜在生物学作用,我们将 miR-548d-3p 抑制剂瞬时转染到 感染的 THP-1 细胞中,发现抑制 miR-548d-3p 增强了寄生虫的生长,可能是通过降低 MCP-1/CCL2 和一氧化氮的产生来介导的。需要进一步的工作来确定 miR-548d-3p 如何发挥作用以及它是否作为进行性利什曼病的潜在生物标志物。